Eptifibatide CAS NO.148031-34-9

product name

eptifibatide;

sequence

mpr-har-gly-asp-trp-pro-cys-nh₂

_{[3-carbamoyl-11-{4-[(diaminomethylidene)amino]butyl}-20-(1h-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7h-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid; [(1s,4r,12s,18s,21s)-12-(4-carbamimidamidobutyl)-4-carbamoyl-21-(1h-indol-3-ylmethyl)-2,10,13,16,19,22-hexaoxo-6,7-dithia-3,11,14,17,20,26-hexaazabicyclo[21.2.1]hexacos-18-yl]acetic acid; map-lys-gly-asp-trp-pro-cys-nh2; integrelin; n6-(aminoiminomethyl)-n2-(3-mercapto-1-oxopropyl-l-lysylglycyl-l-a-aspartyl-l-tryptophyl-l-prolyl-l-cysteinamide; [(3r,11s,17s,20s,25as)-11-(4-carbamimidamidobutyl)-3-carbamoyl-20-(1h-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxodocosahydro-7h-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosin-17-yl]acetic acid}

cas no.

148031-34-9

molecular formula

c₃₅h₄₉n₁₁o₉s₂

molecular weight

832.4

appearance

white slightly yellwish powder

specific rotation[20/d]

-75.0～-95.0°（c=1，1%hac）

amino acids composition

± 10%

peptide purity (by hplc)

≥98% by area integration

related substance (by hplc)

total impurities (%)≤2.0% largest single impurity (%)≤ 1.0%

water content (karl fischer)

≤8.0%

peptide content(n determination)

≥80%

acetate content

≤15%

ir spectrum

in accordance